Current assets increased 89.0%
Current assets changed +89.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$528.3M→$998.6M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KYMR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital increased 99.0%
Working capital changed +99.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$456.7M→$908.9M4 prior comparisons
Revenue decreased 100.0%
Revenue changed -100.0% from the comparable as-filed period.
$2.8M→$02 prior comparisons
Current liabilities increased 25.4%
Current liabilities changed +25.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$71.6M→$89.7M4 prior comparisons
Free-cash-flow proxy decreased 186.6%
Free-cash-flow proxy changed -186.6% from the comparable as-filed period.
-$27.3M→-$78.2M2 prior comparisons
Operating income decreased 59.1%
Operating income changed -59.1% from the comparable as-filed period.
-$92.5M→-$147.2M2 prior comparisons
Operating cash flow decreased 187.4%
Operating cash flow changed -187.4% from the comparable as-filed period.
-$27.1M→-$77.9M2 prior comparisons
Shares outstanding increased 18.7%
Shares outstanding changed +18.7% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
71,949,027→85,371,3978 prior comparisons
Net income decreased 60.6%
Net income changed -60.6% from the comparable as-filed period.
-$82.2M→-$132.0M2 prior comparisons
Research & development increased 73.4%
Research & development changed +73.4% from the comparable as-filed period.
$74.1M→$128.5M2 prior comparisons
Working capital / assets moved 998 bp higher
Working capital / assets changed +998 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
41.44%→51.43%4 prior comparisons
Cash & equivalents increased 230.6%
Cash & equivalents changed +230.6% from the comparable as-filed period.
$112.9M→$373.4M2 prior comparisons
Capital expenditure increased 74.0%
Capital expenditure changed +74.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$181,000→$315,0002 prior comparisons
Total assets increased 60.4%
Total assets changed +60.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.1B→$1.8B4 prior comparisons
Current ratio increased 50.8%
Current ratio changed +50.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
7.38→11.134 prior comparisons
Cost of revenue decreased 100.0%
Cost of revenue changed -100.0% from the comparable as-filed period.
$2.8M→$02 prior comparisons
Stock-based compensation increased 19.2%
Stock-based compensation changed +19.2% from the comparable as-filed period.
$15.8M→$18.8M2 prior comparisons
Working capital / assets moved 1618 bp lower
Working capital / assets changed -1618 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
56.65%→40.47%4 prior comparisons
Operating margin moved 62050 bp higher
Operating margin changed +62050 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-736.82%→-116.32%2 prior comparisons
Revenue increased 466.4%
Revenue changed +466.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$11.5M→$65.0M2 prior comparisons
Cash & equivalents decreased 62.9%
Cash & equivalents changed -62.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$335.8M→$124.5M2 prior comparisons
Research & development increased 52.4%
Research & development changed +52.4% from the comparable as-filed period.
$78.4M→$119.5M2 prior comparisons
Net income increased 20.1%
Net income changed +20.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$76.6M→-$61.2M2 prior comparisons
Cost of revenue increased 466.4%
Cost of revenue changed +466.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$11.5M→$65.0M2 prior comparisons
Capex / revenue moved 533 bp lower
Capex / revenue changed -533 basis points from the comparable as-filed period.
6.06%→0.73%2 prior comparisons
Total assets increased 45.5%
Total assets changed +45.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.1B→$1.6B4 prior comparisons
Operating income increased 10.6%
Operating income changed +10.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$84.6M→-$75.6M2 prior comparisons
Shares outstanding increased 16.3%
Shares outstanding changed +16.3% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
71,497,597→83,150,6188 prior comparisons
SBC / revenue moved 10519 bp lower
SBC / revenue changed -10519 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
134.32%→29.14%2 prior comparisons
Free-cash-flow proxy increased 10.0%
Free-cash-flow proxy changed +10.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$60.6M→-$54.5M3 prior comparisons
Operating cash flow increased 9.7%
Operating cash flow changed +9.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$59.9M→-$54.1M3 prior comparisons
Trade receivables decreased 50.0%
Trade receivables changed -50.0% from the comparable as-filed period.
$40.0M→$20.0M1 prior comparisons
R&D / revenue moved 49924 bp lower
R&D / revenue changed -49924 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
683.06%→183.82%2 prior comparisons
Operating cash-flow margin moved 43864 bp higher
Operating cash-flow margin changed +43864 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-521.82%→-83.18%2 prior comparisons
Free-cash-flow margin moved 44397 bp higher
Free-cash-flow margin changed +44397 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-527.88%→-83.90%2 prior comparisons
Current liabilities decreased 18.5%
Current liabilities changed -18.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$87.5M→$71.3M4 prior comparisons
Stock-based compensation increased 22.9%
Stock-based compensation changed +22.9% from the comparable as-filed period.
$15.4M→$18.9M2 prior comparisons
Capital expenditure decreased 31.9%
Capital expenditure changed -31.9% from the comparable as-filed period.
$695,000→$473,0003 prior comparisons
Receivables / revenue moved 31778 bp lower
Receivables / revenue changed -31778 basis points from the comparable as-filed period.
348.55%→30.77%0 prior comparisons
Current ratio increased 24.2%
Current ratio changed +24.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
8.32→10.344 prior comparisons
Working capital increased 3.9%
Working capital changed +3.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$640.8M→$665.9M4 prior comparisons
Gross margin moved 0 bp unchanged
Gross margin changed +0 basis points from the comparable as-filed period.
0.00%→0.00%2 prior comparisons
Current assets increased 1.2%
Current assets changed +1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$728.3M→$737.3M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.